Why the study?
FFR accurately assesses the functional significance of coronary stenosis, but there is a dearth of data using FFR in triple vessel disease.
Does fractional flow reserve-guided management alter treatment plans and improve clinical and functional outcomes compared to quantitative coronary angiography-based assessment in patients with intermediate triple vessel coronary artery disease?
Does fractional flow reserve-guided management alter treatment plans and improve clinical and functional outcomes compared to quantitative coronary angiography-based assessment in patients with intermediate triple vessel coronary artery disease?
In Indian patients with intermediate triple vessel coronary artery disease, FFR-guided management altered the treatment strategy in 15.2% of patients—averting CABG in one-third of planned surgical cases—with low 12-month adverse event rates and 83.5% of patients remaining asymptomatic.
Answers are grounded in this paper and cite their sources.
May inform revascularization choices in triple-vessel disease; leaves open outcome benefits versus CAG alone.
BACKGROUND: Fractional Flow Reserve (FFR) helps to assess the functional significance of a coronary stenosis accurately, particularly in triple vessel disease (TVD) where other modalities are ineffectual. There is dearth of data using FFR in TVD. In this study, we assessed outcome of FFR guided management in a spectrum of TVD. METHODS: A prospective observational study was conducted at four tertiary care hospitals of the armed forces between Aug 2019 and Aug 2023. Patients diagnosed with intermediate TVD on coronary angiogram (CAG) were included in the study. Initial treatment strategy based on CAG was noted. Treatment was reformulated based on FFR findings. Primary end points of death, myocardial infarction, repeat revascularization and stroke were evaluated at 3, 6 and 12 months. RESULTS: 145 patients were studied. 60 % presented with acute coronary syndrome (ACS). None of the mild stenosis (30-50 %) were found to be FFR positive in any of the vessels. 4.8 % lesions in LAD, 6.2 % lesions in LCx and 2.8 % lesions in RCA were found to be functionally non-significant despite having >70 % stenosis. Post FFR treatment variation was seen in 8.3 % in PCI group and surgery was averted in 33.3 % of CABG group. All-cause mortality was 3.5 %, 1.4 % had stroke and 1.4 % of patients required repeat revascularization. 83.5 % of all patients remained asymptomatic post intervention at 12 months follow-up. CONCLUSIONS: FFR guided management lead to change of plan in a substantial 15.2 % of patients when compared to CAG based management. FFR negativity in LAD was the main reason for majority of TVD patients ending up with PCI instead of CABG.
No takes yet. Share an insight, caveat, or question.
Murthy et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: